留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

再生医学在战创伤早期救治中的作用及展望

田光磊 程飚 付小兵

田光磊, 程飚, 付小兵. 再生医学在战创伤早期救治中的作用及展望[J]. 中华烧伤与创面修复杂志, 2023, 39(5): 411-416. DOI: 10.3760/cma.j.cn501225-20220419-00147.
引用本文: 田光磊, 程飚, 付小兵. 再生医学在战创伤早期救治中的作用及展望[J]. 中华烧伤与创面修复杂志, 2023, 39(5): 411-416. DOI: 10.3760/cma.j.cn501225-20220419-00147.
Tian GL,Cheng B,Fu XB.Role and prospect of regenerative medicine in early treatment of combat trauma[J].Chin J Burns Wounds,2023,39(5):411-416.DOI: 10.3760/cma.j.cn501225-20220419-00147.
Citation: Tian GL,Cheng B,Fu XB.Role and prospect of regenerative medicine in early treatment of combat trauma[J].Chin J Burns Wounds,2023,39(5):411-416.DOI: 10.3760/cma.j.cn501225-20220419-00147.

再生医学在战创伤早期救治中的作用及展望

doi: 10.3760/cma.j.cn501225-20220419-00147
基金项目: 

国家自然科学基金面上项目 82172223

军事医学创新工程专项 18CXZ029

详细信息
    通讯作者:

    付小兵,Email:fuxiaobing@vip.sina.com

Role and prospect of regenerative medicine in early treatment of combat trauma

Funds: 

General Program of National Natural Science Foundation of China 82172223

Military Medical Innovation Special Project 18CXZ029

More Information
  • 摘要: 再生医学在战创伤修复中已取得巨大突破,展现出广阔前景,但其在战创伤早期救治中的应用方法尚不够明确。战创伤早期的救治需严格控制出血、补充大量血液、减轻酸中毒、纠正低体温和改善凝血功能障碍。该文将从生物工程化血液、止血材料的研发、炎症/感染控制与免疫调控、重要脏器的保护、军事医学研究模型建立、生物传感器与药物的研发以及干细胞库在国防医学中再生与组织工程的预防式应用等方面概括再生医学在战创伤早期救治中的作用,希望有助于提高战创伤整体救治水平。

     

  • 参考文献(40)

    [1] 付小兵.中国组织修复与再生医学健康发展的思考与实践[J].中华创伤杂志,2021,37(7):580-585.DOI: 10.3760/cma.j.cn501098-20210525-00319.
    [2] UdeCC,MiskonA,IdrusR,et al.Application of stem cells in tissue engineering for defense medicine[J].Mil Med Res,2018,5(1):7.DOI: 10.1186/s40779-018-0154-9.
    [3] ChewLH, DhillonP. Identifying type Os: spelling out the future of red blood cell products in military medicine[J]. J Military, Veteran Family Health, 2022,8 (s2): 123-131. DOI: 10.3138/jmvfh-2021-0123.
    [4] CapAP,CannonJW,ReadeMC.Synthetic blood and blood products for combat casualty care and beyond[J].J Trauma Acute Care Surg,2021,91(2S Suppl 2):S26-32.DOI: 10.1097/TA.0000000000003248.
    [5] KhanF,SinghK,FriedmanMT.Artificial blood: the history and current perspectives of blood substitutes[J].Discoveries (Craiova),2020,8(1):e104.DOI: 10.15190/d.2020.1.
    [6] LucNF,RohnerN,GirishA,et al.Bioinspired artificial platelets: past, present and future[J].Platelets,2022,33(1):35-47.DOI: 10.1080/09537104.2021.1967916.
    [7] PopovskyMA,WhiteN.Spray-dried plasma: a post-traumatic blood "bridge" for life-saving resuscitation[J].Transfusion,2021,61 Suppl 1:S294-300.DOI: 10.1111/trf.16536.
    [8] MokG,HoangR,KhanMW,et al.Freeze-dried plasma for major trauma - systematic review and meta-analysis[J].J Trauma Acute Care Surg,2021,90(3):589-602.DOI: 10.1097/TA.0000000000003012.
    [9] PusateriAE, WeiskopfRB.Dried plasma for trauma resuscitation[J]. Plasma, 2021:705-718. DOI: 10.1007/978-3-030-53606-0_42.
    [10] 郭栋,张戎,黎檀实,等.现代战伤现场急救止血理论、技术与器材[J].中华灾害救援医学,2021,9(6):1066-1070.DOI: 10.13919/j.issn.2095-6274.2021.06.011.
    [11] Feingerts B Efficacy of QuikClot combat gauze when used by immediate responders in a simulated gunshot wound Connecticut Yale School of Medicine 2021

    FeingertsB. Efficacy of QuikClot combat gauze when used by immediate responders in a simulated gunshot wound[D]. Connecticut:Yale School of Medicine,2021.

    [12] YuP,ZhongW.Hemostatic materials in wound care[J/OL].Burns Trauma,2021,9:tkab019[2022-04-19].https://pubmed.ncbi.nlm.nih.gov/34541007/.DOI: 10.1093/burnst/tkab019.
    [13] AnsariA, KhosronezhadF, ShallagehY, et al. A review of hemostatic agents and products[J]. Scientific J Iran Blood Transfus Organ, 2021, 18(4): 291-312.
    [14] TompeckAJ,GajdharAUR,DowlingM,et al.A comprehensive review of topical hemostatic agents: the good, the bad, and the novel[J].J Trauma Acute Care Surg,2020,88(1):e1-e21.DOI: 10.1097/TA.0000000000002508.
    [15] MalikA,RehmanFU,ShahKU,et al.Hemostatic strategies for uncontrolled bleeding: a comprehensive update[J].J Biomed Mater Res B Appl Biomater,2021,109(10):1465-1477.DOI: 10.1002/jbm.b.34806.
    [16] GhimireS,SarkarP,RigbyK,et al.Polymeric materials for hemostatic wound healing[J].Pharmaceutics,2021,13(12):2127.DOI: 10.3390/pharmaceutics13122127.
    [17] MohamedE, FitzgeraldA, TsuzukiT. The role of nanoscale structures in the development of topical hemostatic agents[J]. Materials Today Nano, 2021, 16: 100137.DOI: 10.1016/j.mtnano.2021.100137.
    [18] SheppardOO,FojeNA.Topical coagulant agents[J].Surg Clin North Am,2022,102(1):65-83.DOI: 10.1016/j.suc.2021.09.004.
    [19] PelteCH,ChawlaLS.Novel therapeutic targets for prevention and therapy of sepsis associated acute kidney injury[J].Curr Drug Targets,2009,10(12):1205-1211.DOI: 10.2174/138945009789753219.
    [20] AmbroseCG, KellamJF, CrawfordL, et al. Incidence, complications, and novel treatment strategies: osteomyelitis[J]. Musculoskeletal Infection, 2022:203-225. DOI: 10.1007/978-3-030-83251-3_7.
    [21] Ayala-CuellarAP,KangJH,JeungEB,et al.Roles of mesenchymal stem cells in tissue regeneration and immunomodulation[J].Biomol Ther (Seoul),2019,27(1):25-33.DOI: 10.4062/biomolther.2017.260.
    [22] HarrellCR,DjonovV,VolarevicV.The cross-talk between mesenchymal stem cells and immune cells in tissue repair and regeneration[J].Int J Mol Sci,2021,22(5):2472.DOI: 10.3390/ijms22052472.
    [23] LiT,LuoC,ZhangJ,et al.Efficacy and safety of mesenchymal stem cells co-infusion in allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis[J].Stem Cell Res Ther,2021,12(1):246.DOI: 10.1186/s13287-021-02304-x.
    [24] ShahK,ShahN,GhassemiF,et al.Alloreactivity of allogeneic mesenchymal stem/stromal cells and other cellular therapies: a concise review[J].Stem Cells Int,2022,2022:9589600.DOI: 10.1155/2022/9589600.
    [25] SalatiSA. Debridement-a review of current techniques[J]. Journal of Pakistan Association of Dermatologists, 2021, 31(2): 262-272.
    [26] DrydenM.Novel techniques in the treatment of skin and soft tissue infection[J].Curr Opin Infect Dis,2022,35(2):72-78.DOI: 10.1097/QCO.0000000000000818.
    [27] SatyamitraMM,CassattDR,TaliaferroLP.Meeting commentary: a poly-pharmacy approach to mitigate acute radiation syndrome (ARS)[J].Radiat Res,2021,196(4):423-428.DOI: 10.1667/RADE-21-00053.1.
    [28] ChangC,YanJ,YaoZ,et al.Effects of mesenchymal stem cell-derived paracrine signals and their delivery strategies[J].Adv Healthc Mater,2021,10(7):e2001689.DOI: 10.1002/adhm.202001689.
    [29] DiCarloAL, TamaratR, RiosCI, et al. Cellular therapies for treatment of radiation injury: report from a NIH/NIAID and IRSN workshop[J]. Radiat Res, 2017,188(2):e54-e75. DOI: 10.1667/RR14810.1.
    [30] WangS,HanY,ZhangJ,et al.Me6TREN targets β-catenin signaling to stimulate intestinal stem cell regeneration after radiation[J].Theranostics,2020,10(22):10171-10185.DOI: 10.7150/thno.46415.
    [31] MizutaY,AkahoshiT,GuoJ,et al.Exosomes from adipose tissue-derived mesenchymal stem cells ameliorate histone-induced acute lung injury by activating the PI3K/Akt pathway in endothelial cells[J].Stem Cell Res Ther,2020,11(1):508.DOI: 10.1186/s13287-020-02015-9.
    [32] 付小兵.组织修复与再生的新挑战:实现多种组织在损伤部位的同步修复与再生[J].中华烧伤杂志,2016,32(1):6-10.DOI: 10.3760/cma.j.issn.1009-2587.2016.01.003.
    [33] YahayaU, AkramM, AbdullahiRI, et al. The role of biosensors and biological weapons in national defence and security operations[J]. Nig J Biotech, 2021, 38(1): 132-136.DOI: 10.4314/njb.v38i1.15.
    [34] RouxJ,ZeghidiM,VillarS,et al.Biosafety and biobanking: current understanding and knowledge gaps[J].Biosaf Health,2021,3(5):244-248.DOI: 10.1016/j.bsheal.2021.06.003.
    [35] SittadjodyS,CriswellT,JacksonJD,et al.Regenerative medicine approaches in bioengineering female reproductive tissues[J].Reprod Sci,2021,28(6):1573-1595.DOI: 10.1007/s43032-021-00548-9.
    [36] Al-HendyA,KuSY.Reproductive tract tissue/organ engineering and regenerative medicine for reproduction[J].Reprod Sci,2021,28(6):1571-1572.DOI: 10.1007/s43032-021-00547-w.
    [37] BhaskarR, GuptaMK, HanSS. Tissue engineering approaches for the in vitro production of spermatids to treat male infertility: a review[J]. European Polymer Journal, 2022,174:111318.DOI.10.1016/j.eurpolymj.2022.111318.
    [38] ZhouP,OuchariM,XueY,et al.In vitro generation of red blood cells from stem cell and targeted therapy[J].Cell Transplant,2020,29:963689720946658.DOI: 10.1177/0963689720946658.
    [39] ÖztürkS,ElçinAE,KocaA,et al.Therapeutic applications of stem cells and extracellular vesicles in emergency care: futuristic perspectives[J].Stem Cell Rev Rep,2021,17(2):390-410.DOI: 10.1007/s12015-020-10029-2.
    [40] KellyLS, DardenDB, FennerBP, et al. The hematopoietic stem/progenitor cell response to hemorrhage, injury, and sepsis: a review of pathophysiology[J]. Shock, 2021, 56(1): 30-41.DOI: 10.1097/SHK.0000000000001699.
  • 加载中
图(1)
计量
  • 文章访问数:  289
  • HTML全文浏览量:  119
  • PDF下载量:  39
  • 被引次数: 0
出版历程
  • 收稿日期:  2022-04-19

目录

    /

    返回文章
    返回